Literature DB >> 29581936

Unsuccessful Xpert® MTB/RIF results: the Nigerian experience.

M Gidado1, N Nwokoye1, P Nwadike1, P Ajiboye1, R Eneogu1, S Useni1, J Onazi1, A Lawanson2, E Elom2, A Tubi2, J Kuye2.   

Abstract

Setting: Nigeria, a high tuberculosis (TB) burden country. Objective: To study the rate, distribution and causes of unsuccessful Xpert® MTB/RIF test outcomes, with the aim of identifying key areas that need to be strengthened for optimal performance of the assay. Design: This was a retrospective analysis of data uploaded between January and December 2015 from Xpert facilities to the central server using GXAlert. Result: Of 52 219 test results uploaded from 176 Xpert machines, 22.5% were positive for Mycobacterium tuberculosis, 10.8% of which were rifampicin-resistant; 4.7% of the total number of results were invalid, 4.2% had error results and 2.1% no result outcomes. Technical errors were most frequent (69%); these were non-seasonal and occurred in all geopolitical regions and at all health facility levels. Temperature-related errors were more prevalent in the North-West Region, with peaks in April to June. Peak periods for temperature and machine malfunction errors coincided with the periods of low utilisation of the assay.
Conclusion: The key challenge affecting performance was poor adherence to standard operating procedures. Periodic refresher training courses, regular supervision, preventive maintenance of Xpert machines and proper storage of cartridges are strategies that could improve Xpert performance.

Entities:  

Keywords:  diagnosis; error; implementation; tuberculosis

Year:  2018        PMID: 29581936      PMCID: PMC5858060          DOI: 10.5588/pha.17.0080

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  16 in total

1.  Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria.

Authors:  M Cruciani; C Scarparo; M Malena; O Bosco; G Serpelloni; C Mengoli
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

Review 2.  Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?

Authors:  Annelies Van Rie; Liesl Page-Shipp; Lesley Scott; Ian Sanne; Wendy Stevens
Journal:  Expert Rev Mol Diagn       Date:  2010-10       Impact factor: 5.225

3.  Retrospective research: What are the ethical and legal requirements?

Authors:  V Junod; B Elger
Journal:  Swiss Med Wkly       Date:  2010-07-25       Impact factor: 2.193

4.  An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis.

Authors:  Deborah A Williamson; Indira Basu; James Bower; Joshua T Freeman; Gillian Henderson; Sally A Roberts
Journal:  Diagn Microbiol Infect Dis       Date:  2012-07-20       Impact factor: 2.803

5.  Molecular analysis of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates by multiple allele specific polymerase chain reaction in Puducherry, South India.

Authors:  Ravibalan Thirumurugan; Maruthai Kathirvel; Kommoju Vallayyachari; Kesavan Surendar; Antony V Samrot; Muthuraj Muthaiah
Journal:  J Infect Public Health       Date:  2015 Nov-Dec       Impact factor: 3.718

6.  Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in India.

Authors:  Neeraj Raizada; Kuldeep Singh Sachdeva; Achuthan Sreenivas; Shubhangi Kulsange; Radhey Shyam Gupta; Rahul Thakur; Puneet Dewan; Catharina Boehme; Chinnambedu Nainarappan Paramsivan
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

7.  Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.

Authors:  Kuldeep Singh Sachdeva; Neeraj Raizada; Achuthan Sreenivas; Anna H Van't Hoog; Susan van den Hof; Puneet K Dewan; Rahul Thakur; R S Gupta; Shubhangi Kulsange; Bhavin Vadera; Ameet Babre; Christen Gray; Malik Parmar; Mayank Ghedia; Ranjani Ramachandran; Umesh Alavadi; Nimalan Arinaminpathy; Claudia Denkinger; Catharina Boehme; C N Paramasivan
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

8.  Evaluating the Diagnostic Accuracy of Xpert MTB/RIF Assay in Pulmonary Tuberculosis.

Authors:  Surendra K Sharma; Mikashmi Kohli; Raj Narayan Yadav; Jigyasa Chaubey; Dinkar Bhasin; Vishnubhatla Sreenivas; Rohini Sharma; Binit K Singh
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

9.  Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.

Authors:  Betina Durovni; Valeria Saraceni; Susan van den Hof; Anete Trajman; Marcelo Cordeiro-Santos; Solange Cavalcante; Alexandre Menezes; Frank Cobelens
Journal:  PLoS Med       Date:  2014-12-09       Impact factor: 11.069

10.  Impact on Patients' Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial.

Authors:  Anete Trajman; Betina Durovni; Valeria Saraceni; Alexandre Menezes; Marcelo Cordeiro-Santos; Frank Cobelens; Susan Van den Hof
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

View more
  11 in total

1.  Epidemiology of molecular probes in Xpert MTB/RIF assay in Khyber Pakhtunkhwa, Pakistan.

Authors:  Anwar Sheed Khan; Muhammad Tahir Khan; Sajid Ali; Taj Ali Khan; Muhammad Qasim; Arif Malik; Sajid Ali; Wasim Sajjad; Qurrat Ul Ain; Muhammad Irfan
Journal:  Arch Microbiol       Date:  2021-02-27       Impact factor: 2.552

2.  Evaluating the efficacy of stool sample on Xpert MTB/RIF Ultra and its comparison with other sample types by meta-analysis for TB diagnostics.

Authors:  Vishal Sharma; Anoop Singh; Mohita Gaur; Deepti Rawat; Anjali Yadav; Chanchal Kumar; Mandira Varma-Basil; Sheelu Lohiya; Vishal Khanna; Ashwani Khanna; Anil Chaudhry; Yogendra Singh; Richa Misra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-05-04       Impact factor: 3.267

3.  Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis.

Authors:  Hou-He Li; Zhi-Jian He; Jia-Qi Liang; Gui-Lin Li; Tian-Ao Xie; Ye-Ling Liu; Zhong-Wei Li; Xuan-Cheng Feng; Yong Xia; Xu-Guang Guo
Journal:  Biomed Res Int       Date:  2020-06-28       Impact factor: 3.411

4.  Xpert negative means no TB: A mixed-methods study into early implementation of Xpert in Puducherry, India.

Authors:  Ariarathinam Newtonraj; Emilie Venables; Kalaiselvi Selvaraj; Debashish Kundu; Anil Jacob Purty; Mani Manikandan; Hemant Deepak Shewade
Journal:  J Family Med Prim Care       Date:  2019-04

5.  Assessment of GeneXpert MTB/RIF Performance by Type and Level of Health-Care Facilities in Nigeria.

Authors:  Mustapha Gidado; Nkiru Nwokoye; Chidubem Ogbudebe; Bassey Nsa; Peter Nwadike; Prisca Ajiboye; Rupert Eneogu; Sani Useni; Emeka Elom; Adebola Lawanson
Journal:  Niger Med J       Date:  2019 Jan-Feb

6.  Improving the design of studies evaluating the impact of diagnostic tests for tuberculosis on health outcomes: a qualitative study of perspectives of diverse stakeholders.

Authors:  Eleanor A Ochodo; Selvan Naidoo; Samuel Schumacher; Karen Steingart; Jon Deeks; Frank Cobelens; Patrick M Bossuyt; Taryn Young; Mark P Nicol
Journal:  Wellcome Open Res       Date:  2019-11-21

7.  Driving the usage of tuberculosis diagnostic data through capacity building in low- and middle-income countries.

Authors:  Natasha Gous; Alaine U Nyaruhirira; Bradford Cunningham; Chris Macek
Journal:  Afr J Lab Med       Date:  2020-11-18

8.  Perspectives and practices of health workers around diagnosis of paediatric tuberculosis in hospitals in a resource-poor setting - modern diagnostics meet age-old challenges.

Authors:  Jacquie Narotso Oliwa; Sabina Adhiambo Odero; Jacinta Nzinga; Michaël Boele van Hensbroek; Caroline Jones; Mike English; Anja Van't Hoog
Journal:  BMC Health Serv Res       Date:  2020-08-01       Impact factor: 2.655

9.  Monitoring quality indicators for the Xpert MTB/RIF molecular assay in Ethiopia.

Authors:  Abebaw Kebede; Dereje Beyene; Bazezew Yenew; Getu Diriba; Zemedu Mehamd; Ayinalem Alemu; Misikr Amare; Gobena Ameni
Journal:  PLoS One       Date:  2019-11-12       Impact factor: 3.240

10.  The Simple One-Step (SOS) Stool Processing Method for Use with the Xpert MTB/RIF Assay for a Child-Friendly Diagnosis of Tuberculosis Closer to the Point of Care.

Authors:  Petra de Haas; Bazezew Yenew; Endale Mengesha; Andrii Slyzkyi; Zewdu Gashu; Manon Lounnas; Ephrem Tesfaye; Ahmed Bedru; Edine Tiemersma; Kristin Kremer; Misikir Amare; Getu Diriba; Betselot Zerihun; Tilaye Gudina; Ben Tegegn; Maryline Bonnet; Challa Negeri; Eveline Klinkenberg
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.